Oct 12 (Reuters) - Spark Therapeutics Inc's experimental gene therapy for a rare form of blindness improves vision and should be approved, advisers to the Food and Drug Administration concluded on Thursday, paving the way for the first U.S. gene therapy for an inherited disease.


00


Reuters

Latest News

Wall Street Journal: T-Mobile to Launch Pay-TV Service

Wall Street Journal: How Language in Job Listings Could Widen Silicon Valley's Gender Divide

Wall Street Journal: With Traffic Flowing, Netflix Steps Back from Fight Over Internet Rules

Wall Street Journal: Disney Finalizing Pact to Acquire Assets from 21st Century Fox

Daily Mail: Busy Philipps accessorizes with a $2,700 Gucci handbag

Daily Mail: Vic Labor Northcote deal referred to IBAC

Reuters: BRIEF-Westwater Resources To Acquire Alabama Graphite Corp

Reuters: BRIEF-PHX Energy Says Has Approved 2018 Capital Expenditure Program Of $10.5 Mln

Reuters: BRIEF-Westwater Resources Acquires Alabama Graphite

Reuters: BRIEF-Mid Penn Bancorp Receives Regulatory Approvals For Scottdale Bank Merger

Reuters: BRIEF-Seven Stars Says Entered Into Securities Purchase Agreement With Tiger Sports Media

Reuters: BRIEF-Remark Holdings Partnering With China Shenhua Energy Company

Reuters: BRIEF-Georgia Power Says Working With At&T For A Georgia-Based Trial Of AT&T's Airgig Technology

Reuters: BRIEF-Sigma Industries Reports Q2 Earnings Per Share $0.01

Reuters: UPDATE 2-Lockheed Martin may top Boeing in race to supply Canada jets -experts

CBS: Trump says Democrats like tax plan "a lot"

BBC: Republican lawmakers say historic tax deal is agreed

Los Angeles Times: L.A. backs requirements that could freeze out Wells Fargo from city contract

USA Today: Army sergeant surprised his kids during Kings game

Daily Mail: Justice Department confirms criminal probe in Uber case

Daily Mail: Puel gets revenge on Southampton as Leicester wins 4-1

Daily Mail: Unstoppable City break record, United edge out Bournemouth

Daily Mail: Soccer-Man City roll over Swansea for 15th straight...